H.R.7854

Medicines for the People Act

Introduced·3/5/26

Establishes a National Institute for Biomedical Research and Development to promote public health.

The Medicines for the People Act establishes a National Institute for Biomedical Research and Development within the Department of Health and Human Services. The Institute aims to develop drugs, devices, and biological products to ensure public health needs are met. It prioritizes public manufacturing and equitable pricing, licensing patents to for-profit entities under terms that protect public interest. The Institute is governed by a Board appointed by the Secretary of Health and Human Services, ensuring diverse representation and expertise.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Energy And Commerce Committee
Next
Committee decision

Sponsors

Democratic CaucusRepublican Caucus

History

Mar 5

House

Introduced in House

Mar 5

House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.